Jim Simons
CRMD icon

Jim Simons’s CorMedix CRMD Stock Holding History

Jim Simons’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-152,200
Closed -$1.88M – 3568
2025
Q2 		$1.88M Buy
+152,200
New +$1.68M ﹤0.01% 2149
2025
Q1 		– Sell
-134,000
Closed -$1.09M – 3521
2024
Q4 		$1.09M Buy
+134,000
New +$1.34M ﹤0.01% 2454
2024
Q3 		– Sell
-160,734
Closed -$696K – 3577
2024
Q2 		$696K Sell
160,734
-77,925
-33% -$396K ﹤0.01% 2526
2024
Q1 		$1.01M Buy
238,659
+2,959
+1% +$10.3K ﹤0.01% 2476
2023
Q4 		$886K Buy
235,700
+129,100
+121% +$444K ﹤0.01% 2487
2023
Q3 		$394K Buy
+106,600
New +$424K ﹤0.01% 2822
2023
Q2 		– Sell
-181,724
Closed -$752K – 3974
2023
Q1 		$752K Buy
181,724
+108,124
+147% +$442K ﹤0.01% 2656
2022
Q4 		$311K Buy
73,600
+60,000
+441% +$212K ﹤0.01% 3201
2022
Q3 		$38K Buy
+13,600
New +$56.6K ﹤0.01% 3817
2022
Q2 		– Sell
-10,157
Closed -$56K – 4269
2022
Q1 		$56K Buy
+10,157
New +$46.5K ﹤0.01% 3892
2021
Q4 		– Sell
-118,001
Closed -$549K – 3940
2021
Q3 		$549K Buy
+118,001
New +$687K ﹤0.01% 2855
2021
Q1 		– Sell
-43,700
Closed -$325K – 3366
2020
Q4 		$325K Buy
+43,700
New +$297K ﹤0.01% 3004
2020
Q2 		– Sell
-128,900
Closed -$463K – 3485
2020
Q1 		$463K Buy
128,900
+72,500
+129% +$410K ﹤0.01% 2794
2019
Q4 		$411K Buy
+56,400
New +$345K ﹤0.01% 2966
2015
Q2 		– Sell
-9,520
Closed -$468K – 3246
2015
Q1 		$468K Buy
+9,520
New +$226K ﹤0.01% 2620

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jim Simons's CRMD Position: Q3 2025 in Review

Jim Simons sold out of CorMedix (CRMD) in Q3 2025, closing a stake of 152,200 shares — an estimated $1.88M sold.

Jim Simons first reported a position in CRMD in Q1 2015 and held it in 15 quarters. The position peaked at $1.88M in Q2 2025. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

  • Jim Simons reported no remaining CorMedix position as of Q3 2025 after selling out during the quarter.
  • Jim Simons sold 152,200 CorMedix shares in Q3 2025, an estimated $1.88M.
  • Jim Simons first reported a position in CorMedix in Q1 2015 and held it in 15 quarters.
  • Jim Simons's CorMedix position peaked at $1.88M in Q2 2025.
  • 190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.